GeoVax Labs (GOVX) Metrics: History & Chart

GeoVax Labs, Inc.(GOVX)

Biotechnology · Smyrna, GA

$0.29-0.03 (-7.81%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.

Smyrna, GA

19 employees

www.geovax.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Alan Dodd

View full financials

Third-Party DCF Estimate (FMP)	$0.43
Price Gap vs Third-Party Estimate	+34.04%

7D Total Return	0.00%
30D Total Return	0.00%
YTD Total Return	0.00%
1Y Total Return	-98.98%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	N/A
2025	N/A
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	87542087542.09
PE Ratio Avg TTM	98472823318.90
PE Ratio Avg 3Y	98472823318.90
Current VS TTM Avg	-11.10%
Current VS 3Y Avg	-11.10%
Current VS 5Y Avg	-11.10%

All Metrics

GOVX Valuation Metrics

GOVX Stock Price Metrics

GOVX Dividend Metrics

GOVX Growth Rate Metrics

GOVX Discounted Cash Flow Metrics

GOVX Returns By Period

GOVX Yearly Returns

GOVX Average Annual Returns By Period (CAGR)

GOVX Revenue Metrics

GOVX PE Ratio Metrics

GOVX PS Ratio Metrics

GOVX PB Ratio Metrics

GOVX Price to Free Cash Flow Ratio Metrics

GOVX Debt to Equity Ratio Metrics

GOVX PEG Ratio Metrics

GOVX FCF Yield

GOVX Earnings Yield

GOVX EBITDA Yield

GOVX OCF Yield

GOVX EV/EBIT Ratio Metrics

GOVX EV/EBITDA Ratio Metrics

GOVX EV/Assets Ratio Metrics

GOVX EV/Sales Ratio Metrics

GOVX Current Ratio Metrics

GOVX Quick Ratio Metrics

GOVX ROIC Metrics

GOVX Return on Assets Metrics

GOVX Return on Equity Metrics

GOVX Net Profit Margin Metrics

GOVX Gross Profit Margin Metrics

GOVX Tax Rate Metrics

PS Ratio	1.79
PS Ratio Avg TTM	1.42
PS Ratio Avg 3Y	2.29
Current VS TTM Avg	+25.86%
Current VS 3Y Avg	-21.91%
Current VS 5Y Avg	-97.70%

PB Ratio	0.83
PB Ratio Avg TTM	1.70
PB Ratio Avg 3Y	1.67
Current VS TTM Avg	-51.12%
Current VS 3Y Avg	-50.38%
Current VS 5Y Avg	-58.96%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.18
Debt/Equity Ratio Avg TTM	0.24
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-23.72%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.00%
Earnings Yield Avg TTM	0.00%
Earnings Yield Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	56367449524.79
Ev/Ebit Ratio Avg TTM	23256969812.44
Ev/Ebit Ratio Avg 3Y	30293318405.97
Current VS TTM Avg	+142.37%
Current VS 3Y Avg	+86.07%
Current VS 5Y Avg	+86.07%

Ev/Ebitda Ratio	21883353401.24
Ev/Ebitda Ratio Avg TTM	9028978492.70
Ev/Ebitda Ratio Avg 3Y	12013818913.04
Current VS TTM Avg	+142.37%
Current VS 3Y Avg	+82.15%
Current VS 5Y Avg	+82.15%

Ev/Assets Ratio	0.01
Ev/Assets Ratio Avg TTM	0.71
Ev/Assets Ratio Avg 3Y	0.69
Current VS TTM Avg	-98.60%
Current VS 3Y Avg	-98.56%
Current VS 5Y Avg	-98.98%

Ev/Sales Ratio	0.76
Ev/Sales Ratio Avg TTM	1.20
Ev/Sales Ratio Avg 3Y	1.28
Current VS TTM Avg	-36.46%
Current VS 3Y Avg	-40.63%
Current VS 5Y Avg	-98.74%

Current Ratio	1.54
Current Ratio Avg TTM	2.19
Current Ratio Avg 3Y	2.46
Current VS TTM Avg	-29.70%
Current VS 3Y Avg	-37.34%
Current VS 5Y Avg	-56.80%

Quick Ratio	1.54
Quick Ratio Avg TTM	2.19
Quick Ratio Avg 3Y	2.46
Current VS TTM Avg	-29.70%
Current VS 3Y Avg	-37.34%
Current VS 5Y Avg	-56.81%

ROIC	(985.20%)
ROIC Avg 3Y	(722.06%)
ROIC Avg 5Y	(310.43%)
Current VS 3Y Avg	-36.44%
Current VS 5Y Avg	-217.36%
Current VS 10Y Avg	-179.41%

ROA	(439.95%)
ROA Avg TTM	(107.14%)
ROA Avg 3Y	(85.15%)
Current VS TTM Avg	-310.65%
Current VS 3Y Avg	-416.68%
Current VS 5Y Avg	-562.13%

ROE	(1160.10%)
ROE Avg TTM	(552.28%)
ROE Avg 3Y	(362.92%)
Current VS TTM Avg	-110.06%
Current VS 3Y Avg	-219.66%
Current VS 5Y Avg	-355.29%

Net Profit Margin	(862.34%)
Net Profit Margin Avg TTM	(126.01%)
Net Profit Margin Avg 3Y	(105.99%)
Current VS TTM Avg	-584.35%
Current VS 3Y Avg	-713.64%
Current VS 5Y Avg	-184.58%

Gross Profit Margin	(628.02%)
Gross Pft Margin Avg TTM	(90.97%)
Gross Pft Margin Avg 3Y	(26.82%)
Current VS TTM Avg	-590.34%
Current VS 3Y Avg	-2241.66%
Current VS 5Y Avg	-9573.50%

Tax Rate	2.70%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A